Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,122.50
(
0.32%
)
S&P ASX All Technology
2,345.80
(
0.76%
)
Brent Oil
75.705
(
0.24%
)
US Dollar vs AUD
1.48986
(
0.02%
)
Bitcoin
26,474.88
(
-0.11%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Albireo Pharma Inc (ALBO)

  7. Albireo Pharma Inc (ALBO) Financials

ALBO

Albireo Pharma Inc

44.15
0.00 (0.0%)
Upgrade to Real-Time

Albireo Pharma Inc. (ALBO) Fundamentals
Albireo Pharma Inc is a commercial-stage biopharmaceutical company. It focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay, which is approved in the United States and Europe; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its Phase 1 lead candidate for the treatment of adult liver diseases; and A2342, it's a lead preclinical candidate for the treatment of adult viral and liver diseases.
SHARE INFORMATION
Market CapUS$ 913,961,644
Shares Outstanding20,701,283
Float20,643,839
Percent Float99.72%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 9,832,000
Latest Fiscal EPSUS$ -1.92
Latest Fiscal Date2022-09-30
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months1,114,000
Insider Holdings Percent0.3
Insider Sold Previous 3 Months185,568
Insider Shares Owned61,098
TRADING INFO
52 Week HighUS$ 45.23
52 Week LowUS$ 16.02
52 Week High ChangeUS$ 107.28
21 Day Moving AverageUS$ 44.15
21 Day Extended Moving AverageUS$ 44.1489
50 Day Moving AverageUS$ 44.15
50 Day Extended Moving AverageUS$ 43.8022
200 Day Moving AverageUS$ 32.8077
200 Day Extended Moving AverageUS$ 36.6309
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.011944
Beta1.0164
Standard Deviation0.192679
R20.083179
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price ChangeUS$ 22.70
180 Day Percent Change105.83%
200 Day Price ChangeUS$ 22.20
200 Day Percent Change101.14%
Year to Date Price ChangeUS$ 22.54
Year to Date Percent Change104.3%

Albireo Pharma Inc. (ALBO) Key Ratios

PROFITABILITY
EBIT Margin-215.2%
EBITDA Margin-214.5%
Pre-Tax Profit Margin-390.6%
Profit Margin Count-3.84%
Gross Margin95.6%
Profit Margin TOT-3.84%
INCOME STATEMENTS
RevenueUS$ 9,832,000
Revenue Per ShareUS$ 0.4749
Revenue (3 Years)US$ 147.71
Revenue (5 Years)US$ 38.24
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio6.30
Leverage Ratio3.20
Quick Ratio5.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 691,485,644
Price to Sales7.01
Price to Free Cash0.00
PE High Last 5 Years2.50
Price To Book4.00
Price To Cash Flow0.00
PE Low Last 5 Years-56.40
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover34.40
Invoice Turnover1.50
Assets Turnover0.20
Return Assets-42.46
Return on Equity-93.08
Return on Capital-82.66

Albireo Pharma Inc. (ALBO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEORonald . H.W Cooper
Employees130
Last Audit-
CIK0001322505
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address53 State Street,19th Floor
19th Floor
Boston, MA 2109
Websitehttps://www.albireopharma.com
Facsimile-
Telephone+1 857 254-5555
Emailmedinfo@albireopharma.com
Your Recent History
NASDAQ
ALBO
Albireo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230609 07:39:47